3D Medicines (Beijing) Co., Ltd.
Clinical trials sponsored by 3D Medicines (Beijing) Co., Ltd., explained in plain language.
A biopharmaceutical company focused on developing and commercializing oncology drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced cancer? early trial of 3D185 begins Results expected Dec 2026 (estimated)